Jigar Raythatha
2020
In 2020, Jigar Raythatha earned a total compensation of $5.9M as President and Chief Executive Officer at CONSTELLATION PHARMACEUTICALS, a 154% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $244,177 |
|---|---|
| Option Awards | $5,061,900 |
| Salary | $544,087 |
| Other | $12,450 |
| Total | $5,862,614 |
Raythatha received $5.1M in option awards, accounting for 86% of the total pay in 2020.
Raythatha also received $244.2K in non-equity incentive plan, $544.1K in salary and $12.5K in other compensation.
Rankings
In 2020, Jigar Raythatha's compensation ranked 1,801st out of 13,090 executives tracked by ExecPay. In other words, Raythatha earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,801 out of 13,090 | 86th |
Division Manufacturing | 695 out of 5,621 | 88th |
Major group Chemicals And Allied Products | 248 out of 2,254 | 89th |
Industry group Drugs | 207 out of 1,954 | 89th |
Industry Pharmaceutical Preparations | 147 out of 1,459 | 90th |
Source: SEC filing on April 23, 2021.
Raythatha's colleagues
We found four more compensation records of executives who worked with Jigar Raythatha at CONSTELLATION PHARMACEUTICALS in 2020.